Ferroptosis in Cancer Treatment: Another Way to Rome.

Ferroptosis in Cancer Treatment: Another Way to Rome.
复制标题

癌症治疗中的铁死亡:通往罗马的另一种方式。

DOI:
10.3389/fonc.2020.571127
复制
发表时间:
2020
影响因子:
4.7
通讯作者:
Hu K
Hu K
中科院分区:
医学3区
文献类型:
--
作者:
Wu Y;Yu C;Luo M;Cen C;Qiu J;Zhang S;Hu K

文献摘要

参考文献

被引文献

相似文献

铁下垂是一种新的程序性细胞死亡类型,与维持体内平衡和疾病的发展密切相关,尤其是癌症。铁下垂导致线粒体功能障碍和细胞内的毒性脂质过氧化,在抑制肿瘤的生长和进展中起着关键作用。本文就铁下垂的分子机制在化疗、靶向治疗、放射治疗、免疫治疗等方面的研究进展作一综述。我们特别关注了不同的联合治疗效果,如协同增敏效应和在传统癌症治疗中使用铁下垂诱导剂时实现的耐药性逆转。最后,我们讨论了铁性下垂在临床应用中的挑战和机遇。纳米技术和其他新技术的应用可能为铁下垂驱动的癌症治疗提供新的方向。
Ferroptosis is a newly described type of programmed cell death and intensively related to both maintaining homeostasis and the development of diseases, especially cancers. Inducing ferroptosis leads to mitochondrial dysfunction and toxic lipid peroxidation in cells, which plays a pivotal role in suppressing cancer growth and progression. Here, we reviewed the existing studies about the molecular mechanisms of ferroptosis involved in different antitumor treatments, such as chemotherapy, targeted therapy, radiotherapy, and immunotherapy. We focused in particular on the distinct combinatorial therapeutic effects such as the synergistic sensitization effect and the drug-resistance reversal achieved when using ferroptosis inducers with conventional cancer therapy. Finally, we discussed the challenges and opportunities in clinical applications of ferroptosis. The application of nanotechnolgy and other novel technologies may provide a new direction in ferroptosis-driven cancer therapies.
DOI: 10.1126/science.aaw9872
发表时间: 2020-04-03
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Badgley MA;Kremer DM;Maurer HC;DelGiorno KE;Lee HJ;Purohit V;Sagalovskiy IR;Ma A;Kapilian J;Firl CEM;Decker AR;Sastra SA;Palermo CF;Andrade LR;Sajjakulnukit P;Zhang L;Tolstyka ZP;Hirschhorn T;Lamb C;Liu T;Gu W;Seeley ES;Stone E;Georgiou G;Manor U;Iuga A;Wahl GM;Stockwell BR;Lyssiotis CA;Olive KP
通讯作者: Olive KP
DOI: 10.1016/j.canlet.2011.12.012
发表时间: 2012-12-31
期刊: Cancer letters
影响因子: 9.7
作者:
Azzam EI;Jay-Gerin JP;Pain D
通讯作者: Pain D
DOI: 10.1016/j.cell.2012.03.042
发表时间: 2012-05-25
期刊: Cell
影响因子: 64.5
作者:
Dixon SJ;Lemberg KM;Lamprecht MR;Skouta R;Zaitsev EM;Gleason CE;Patel DN;Bauer AJ;Cantley AM;Yang WS;Morrison B 3rd;Stockwell BR
通讯作者: Stockwell BR
DOI: 10.18632/oncotarget.25794
发表时间: 2018-08-17
期刊: Oncotarget
影响因子: --
作者:
Cobler L;Zhang H;Suri P;Park C;Timmerman LA
通讯作者: Timmerman LA
DOI: 10.1038/s41419-019-1897-2
发表时间: 2019-09-17
影响因子: 9
作者:
Bi, Jianling;Yang, Shujie;Meng, Xiangbing
通讯作者: Meng, Xiangbing